The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Primary Sjögren Syndrome: Clinical and Immunologic Disease Patterns in a Cohort of 400 Patients
Abstract
Introduction Sjögren syndrome (SS) is a systemic autoimmune disease that mainly affects the exocrine glands and usually presents as persistent dryness of the mouth and eyes due to functional impairment of the salivary and lacrimal glands (12). In the absence of an associated systemic autoimmune disease, patients with this condition are classified as having primary SS. The histologic hallmark is a focal lymphocytic infiltration of the exocrine glands, and the spectrum of the disease extends from an organ-specific autoimmune disease (autoimmune exocrinopathy) (50) to a systemic process with diverse extraglandular manifestations (11,19,42–44,47). The question that arises is whether epidemiologic factors (such as gender or age at onset of disease) or immunologic patterns, among other factors, are associated with particular disease expressions and define some specific primary SS subsets (10,22,41). Several studies have addressed this problem with results that are controversial due to the small number of patients studied or the different classification criteria applied (14,23,40). We analyzed the prevalence and characteristics of clinical and immunologic manifestations in a large cohort of Spanish patients with primary SS in order to define the different clinical and immunologic patterns of disease expression. (For information on the hematologic features of primary SS, see the article by Ramos-Casals and colleagues in this issue [42a].) Methods Patients Between 1994 and 2000, we investigated the clinical and immunologic characteristics of 400 consecutive patients with primary SS in our units. All patients fulfilled 4 or more of the preliminary diagnostic criteria for SS proposed by the European Community Study Group in 1993 (55) and underwent a complete history and physical examination. Diagnostic tests for SS (rose bengal staining, Schirmer test, parotid scintigraphy, and salivary gland biopsy) were applied according to the recommendations of the European Community Study Group (55), and clinical and serologic characteristics of all patients were collected in a protocol form. Salient features included in the protocol were 1) age at disease onset, defined as the initial manifestation clearly attributable to SS; 2) age at inclusion, defined as the age when the patient entered the protocol; 3) cumulative clinical manifestations during disease evolution (from the onset until protocol inclusion); 4) laboratory findings at protocol inclusion. Definition of clinical features The clinical manifestations evaluated were defined as follows: Articular involvement: arthralgia and/or nonerosive arthritis characterized by tenderness, swelling, or effusion involving 2 or more peripheral joints. We excluded patients with osteoarthritis, nonspecific painful processes, and chronic fatigue. Fever: axillary temperature >37.5 °C, not associated with infectious processes. Lymphadenopathy: enlarged nodes (>1 cm) in the cervical, axillary, or inguinal regions. Cutaneous vasculitis demonstrated by cutaneous purpura and/ or rash. Skin biopsy showing vasculitis when performed. Raynaud phenomenon: intermittent attacks of digital pallor followed by cyanosis and/or rubor of the fingers, toes, ears, nose, tongue, induced by exposure to cold, stress, or both, in the absence of any other associated disease or anatomical abnormality. Peripheral neuropathy: paresthesias, numbness, and/or motor defects of the lower/upper extremities confirmed by electromyography. Sural nerve biopsy showing vasculitis involving vasa nervorum when performed. Nephropathy: presence of persistent proteinuria >0.5 g/day, altered urinalysis (hematuria, pyuria, red blood cell casts), renal tubular acidosis, interstitial nephritis, or glomerulonephritis. Lung involvement: persistent cough and/or dyspnea, with chronic diffuse interstitial infiltrates on X-ray, altered pattern on pulmonary function studies, and/or evidence of pulmonary alveolitis/fibrosis in computed tomography scan. Autoimmune thyroiditis: altered thyroid function with positive antithyroidal autoantibodies. Immunologic studies Immunologic tests included antinuclear antibodies (ANA) (indirect immunofluorescence using mouse liver/kidney/stomach as substrates), antimitochondrial antibodies, antiparietal cell antibodies, antismooth muscle antibodies (SMA), and antiliver-kidney microsome antibodies type-1 (indirect immunofluorescence), precipitating antibodies to the extractable nuclear antigens (ENA) Sm, RNP, Ro/SS-A, and La/SS-B (ELISA), antineutrophil cytoplasmic antibodies (indirect immunofluorescence), antithyroglobulin and antithyroid peroxidase autoantibodies (ELISA), and rheumatoid factor (RF) (latex fixation and Waaler-Rose tests). Complement factors (C3 and C4) were measured by nephelometry (Behring BNA nephelometer) (1). Serum cryoglobulins were measured after centrifugation. Statistical analysis The chi-square and Fisher exact tests were applied to analyze qualitative differences. To compare quantitati
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vitali, C., Bombardieri, S., Moutsopoulos, H. M., Balestrieri, G., Bencivelli, W., Bernstein, R. M., Bjerrum, K. B., Braga, S., Coll, J., Vita, S. D., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360309 · Cited by 1,436
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.
Bloch, K. J., Buchanan, W. W., Wohl, M. J., & Bunim, J. J. (1965) · PubMed · Cited by 881
SJÖGRENʼS SYNDROME: A Clinical, Pathological, and Serological Study of Sixty-two Cases
BLOCH, K. J., BUCHANAN, W. W., WOHL, M. J., & BUNIM, J. J. (1965) · Medicine · doi:10.1097/00005792-196505000-00001 · Cited by 785
Clinical evolution, and morbidity and mortalityof primary Sjögren's syndrome
Skopouli, F. N., Dafni, U., Ioannidis, J. P. A., & Moutsopoulos, H. M. (2000) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(00)80016-5 · Cited by 488
Vitali, C., Bombardieri, S., Moutsopoulos, H. M., Coll, J., Gerli, R., Hatron, P. Y., Kater, L., Konttinen, Y. T., Manthorpe, R., Meyer, O., et al. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.2.116 · Cited by 464
Anti‐Ro (SS‐A) and Anti‐La (SS‐B) in patients with Sjögren's syndrome
Harley, J. B., Alexander, E. L., Bias, W. B., Fox, O. F., Provost, T. T., Reichlin, M., Yamagata, H., & Arnett, F. C. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290207 · Cited by 337
SALIVARY AND ORAL COMPONENTS OF SJÖGREN’S SYNDROME
Daniels, T. E., & Fox, P. C. (1992) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00317-3 · Cited by 212
Late onset systemic lupus erythematosus
Baker, S. B., Rovira, J. R., Campion, E. W., & Mills, J. A. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91109-4 · Cited by 160
Ramos‐Casals, M., Font, J., García‐Carrasco, M., et al. (2002) · Medicine · doi:10.1097/00005792-200207000-00004 · Cited by 148
Self-citationPrimary Sjogren's syndrome in the North East of England: a long-term follow-up study
Davidson, B., Kelly, C. A., & Griffiths, I. D. (1999) · British journal of rheumatology · doi:10.1093/rheumatology/38.3.245 · Cited by 126
Cited by
Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients
Delalande, S., de Seze, J., Fauchais, A.-L., Hachulla, E., Stojkovic, T., Ferriby, D., Dubucquoi, S., Pruvo, J.-P., Vermersch, P., & Hatron, P.-Y. (2004) · Medicine · doi:10.1097/01.md.0000141099.53742.16 · Cited by 647
The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy
Mori, K., Iijima, M., Koike, H., Hattori, N., Tanaka, F., Watanabe, H., Katsuno, M., Fujita, A., Aiba, I., Ogata, A., et al. (2005) · Brain · doi:10.1093/brain/awh605 · Cited by 550
The epidemiology of Sjögren’s syndrome
Shahane, A., & Patel, R. (2014) · Clinical Epidemiology · doi:10.2147/clep.s47399 · Cited by 354
Mariette, X., Seror, R., Quartuccio, L., Baron, G., Salvin, S., Fabris, M., Desmoulins, F., Nocturne, G., Ravaud, P., & De Vita, S. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203991 · Cited by 329
Pulmonary manifestations of Sjögren's syndrome
Flament, T., Bigot, A., Chaigne, B., Henique, H., Diot, E., & Marchand-Adam, S. (2016) · European Respiratory Review · doi:10.1183/16000617.0011-2016 · Cited by 327
Metadata
- Authors
- GARCÍA-CARRASCO, M., RAMOS-CASALS, M., ROSAS, J., PALLARÉS, L., CALVO-ALEN, J., CERVERA, R., FONT, J., & INGELMO, M.
- Venue
- Medicine
- Published
- 2002-07
- Volume
- 81
- Issue
- 4
- Pages
- 270-280
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2010111291
- Cited by
- 443
- References
- 18
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary Sjögren Syndrome: Clinical and Immunologic Disease Patterns in a Cohort of 400 Patients. https://app.cochat.ai/papers/10.1097/00005792-200207000-00003
- The paper
- GARCÍA-CARRASCO, M., RAMOS-CASALS, M., ROSAS, J., PALLARÉS, L., CALVO-ALEN, J., CERVERA, R., FONT, J., & INGELMO, M. (2002). Primary Sjögren Syndrome: Clinical and Immunologic Disease Patterns in a Cohort of 400 Patients. Medicine. https://doi.org/10.1097/00005792-200207000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.